JP2024534173A5 - - Google Patents

Info

Publication number
JP2024534173A5
JP2024534173A5 JP2024513202A JP2024513202A JP2024534173A5 JP 2024534173 A5 JP2024534173 A5 JP 2024534173A5 JP 2024513202 A JP2024513202 A JP 2024513202A JP 2024513202 A JP2024513202 A JP 2024513202A JP 2024534173 A5 JP2024534173 A5 JP 2024534173A5
Authority
JP
Japan
Prior art keywords
pharmaceutically acceptable
treatment
acceptable salt
mads
mandibular advancement
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024513202A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024534173A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/041990 external-priority patent/WO2023034265A1/en
Publication of JP2024534173A publication Critical patent/JP2024534173A/ja
Publication of JP2024534173A5 publication Critical patent/JP2024534173A5/ja
Pending legal-status Critical Current

Links

JP2024513202A 2021-08-31 2022-08-30 睡眠時無呼吸を治療するための方法及び組成物 Pending JP2024534173A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163239064P 2021-08-31 2021-08-31
US63/239,064 2021-08-31
PCT/US2022/041990 WO2023034265A1 (en) 2021-08-31 2022-08-30 Methods and compositions for treating sleep apnea

Publications (2)

Publication Number Publication Date
JP2024534173A JP2024534173A (ja) 2024-09-18
JP2024534173A5 true JP2024534173A5 (cg-RX-API-DMAC7.html) 2025-09-08

Family

ID=83448045

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024513202A Pending JP2024534173A (ja) 2021-08-31 2022-08-30 睡眠時無呼吸を治療するための方法及び組成物

Country Status (8)

Country Link
US (1) US20240358709A1 (cg-RX-API-DMAC7.html)
EP (1) EP4395721A1 (cg-RX-API-DMAC7.html)
JP (1) JP2024534173A (cg-RX-API-DMAC7.html)
KR (1) KR20240053061A (cg-RX-API-DMAC7.html)
CN (1) CN117956959A (cg-RX-API-DMAC7.html)
AU (1) AU2022340532A1 (cg-RX-API-DMAC7.html)
CA (1) CA3230016A1 (cg-RX-API-DMAC7.html)
WO (1) WO2023034265A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024220343A1 (en) * 2023-04-18 2024-10-24 Apnimed, Inc. (Delaware) Combination of a norepinephrine reuptake inhibitor and a melatonin receptor agonist for use in treating sleep apnea

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4522811A (en) 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
GEAP202416602A (en) * 2017-04-28 2024-10-10 Brigham & Womens Hospital Inc Methods and compositions for treating sleep apnea

Similar Documents

Publication Publication Date Title
JP2023139000A5 (cg-RX-API-DMAC7.html)
JP2009525343A5 (cg-RX-API-DMAC7.html)
JP2015512406A5 (cg-RX-API-DMAC7.html)
JP2023181322A (ja) 睡眠時無呼吸を治療するための方法および組成物
HRP20160189T1 (hr) Liječenje crohnove bolesti lakvinimodom
JP2020517719A5 (cg-RX-API-DMAC7.html)
JP2005517669A5 (cg-RX-API-DMAC7.html)
JP2006509751A5 (cg-RX-API-DMAC7.html)
JP2009541443A5 (cg-RX-API-DMAC7.html)
JP2017528507A5 (cg-RX-API-DMAC7.html)
JP2005512995A5 (cg-RX-API-DMAC7.html)
JP2005533860A5 (cg-RX-API-DMAC7.html)
AU2011231645A2 (en) Fast dissolving drug delivery systems
TW200808295A (en) Use of agomelatine in obtaining medicaments intended for the treatment of generalized anxiety disorder
RU2018136580A (ru) Цитратная соль (s)-4-((s)-3-фтор-3-(2-(5,6,7,8-тетрагидро-1,8-нафтиридин-2-ил)этил)пирролидин-1-ил)-3-(3-(2-метоксиэтокси)фенил)бутановой кислоты
JP2009504774A5 (cg-RX-API-DMAC7.html)
JP2008533127A5 (cg-RX-API-DMAC7.html)
JP2024534173A5 (cg-RX-API-DMAC7.html)
JP2013536837A5 (cg-RX-API-DMAC7.html)
JP2006526595A5 (cg-RX-API-DMAC7.html)
JP2024511091A5 (cg-RX-API-DMAC7.html)
JP2008509147A5 (cg-RX-API-DMAC7.html)
JP2024523876A5 (cg-RX-API-DMAC7.html)
JP2009545593A5 (cg-RX-API-DMAC7.html)
US11207330B2 (en) Mirtazapine for use in medication overuse headache based on tension-type headache